TYPE-I DIABETES-MELLITUS - LESSONS FOR HUMAN AUTOIMMUNITY

被引：0
作者：
PUGLIESE, A [1 ]
EISENBARTH, GS [1 ]
机构：
[1] HARVARD UNIV,SCH MED,JOSLIN DIABET CTR,IMMUNOL & IMMUNOGENET SECT,1 JOSLIN PL,BOSTON,MA 02115
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1992年 / 120卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：363 / 366
页数：4
相关论文
共 50 条
[31]   OPTIC NEUROPATHY IN TYPE-I DIABETES-MELLITUS [J].
HOMBERG, M ;
TSCHOPE, D ;
GREBER, H ;
HACKLANDER, T ;
SCHWIPPERT, B ;
GRIES, FA ;
MODDER, U .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1993, 118 (09) :290-295
[32]   PSYCHOSOMATIC THERAPY - TYPE-I DIABETES-MELLITUS [J].
SCHULERSCHNEIDER, A .
PRAXIS DER PSYCHOTHERAPIE UND PSYCHOSOMATIK, 1987, 32 (05) :242-249
[33]   IMMUNOTHERAPY OF RECENT TYPE-I DIABETES-MELLITUS [J].
ASSAN, R .
ANNALES DE MEDECINE INTERNE, 1985, 136 (06) :451-452
[34]   CARDIOMYOPATHY IN CHILDHOOD TYPE-I DIABETES-MELLITUS [J].
HAUSDORF, G ;
RIEGER, U ;
KOEPP, P .
PEDIATRIC RESEARCH, 1987, 22 (02) :218-218
[35]   SERUM OSTEOCALCIN IN TYPE-I DIABETES-MELLITUS [J].
KRUSE, K ;
KRACHT, U .
MONATSSCHRIFT KINDERHEILKUNDE, 1985, 133 (08) :621-621
[36]   EFFECTOR MECHANISMS IN TYPE-I DIABETES-MELLITUS [J].
NERUP, J ;
MANDRUPPOULSEN, T ;
MOLVIG, J .
ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY, 1986, D137 (03) :463-468
[37]   EXPERIMENTAL IMMUNOPREVENTION OF TYPE-I DIABETES-MELLITUS [J].
BOITARD, C ;
TIMSIT, J ;
SEMPE, P ;
BACH, JF .
DIABETES-METABOLISM REVIEWS, 1991, 7 (01) :15-33
[38]   EXTREME HYPERLIPIDEMIA IN TYPE-I DIABETES-MELLITUS [J].
PONDER, SW ;
ELERIAN, L ;
TRAVIS, LB .
CLINICAL PEDIATRICS, 1993, 32 (06) :375-376
[39]   ADRENAL MEDULLITIS IN TYPE-I DIABETES-MELLITUS [J].
BROWN, FM ;
SMITH, AM ;
LONGWAY, S ;
RABINOWE, SL .
CLINICAL RESEARCH, 1990, 38 (02) :A526-A526
[40]   INSULIN-DEPENDENT (TYPE-I) DIABETES-MELLITUS [J].
RODGER, W .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1991, 145 (10) :1227-1237
12345